Sick of corporate greed

The scandal of expensive medicines

In spite of advances in medical innovation, millions of people around the world suffer and die from treatable conditions because medicines are too expensive.
Historically this has tragically affected low and middle-income countries. But in recent years, the NHS has also struggled to pay extortionate prices and has had to turn down or ration new medicines. 
 

Corporate profits trump public health

Why are medicines so expensive? Drug companies can charge runaway prices because new drugs are protected by legal monopolies. This profit-driven model has made the pharmaceutical industry the most profitable in the world. Drug companies justify high prices by claiming they need to recoup their research and development costs. But nine of the top ten pharmaceutical companies spend more on marketing than on research and development. Also, most early-stage innovative research is publically funded. Drug companies often buy up taxpayer funded research and reap the profits from charging extortionate prices while patients are denied access to vital medicines.

Join the fight for affordable medicines

We’ve joined forces with Missing Medicines – a coalition of UK organisations fighting for affordable medicines globally. We want conditions on all public health research to make sure the medicines developed are affordable and accessible here in the UK and across the world.

Latest Blog Posts

It's time to get privatised medicines out of our public health system


03 December 2018

It’s good news for the NHS and patients. After years of big pharma having patent control over a medicine and hiking up its price extortionately, a drug that treats rheumatoid arthritis and Crohn's disease, adalimumab, is being replaced with much cheaper alternatives.

We need the people's prescription to fix pharma


19 October 2018

Our new report ‘The people’s prescription: Re-imagining health innovation to deliver public value’ reveals how pharmaceutical companies not only charge unaffordable prices for medicines, they are also not delivering the drugs we need. It’s a scandal of our time but there are alternatives to a system that puts profits above public need. 

Challenging the corporate control of medicines: 10 highlights


08 October 2018

Amazingly it’s one year on from the launch of our pharmaceuticals campaign. Time has flown, but together, we’ve achieved a lot. A huge thank you to all our supporters, members and local groups for challenging the corporate control of medicines.